Editorial: Rare musculoskeletal disorders: disease mechanisms and therapies
| dc.contributor.author | Seefried, Lothar | |
| dc.contributor.author | Bravenboer, Nathalie | |
| dc.contributor.author | Imel, Erik A. | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2024-01-25T10:48:42Z | |
| dc.date.available | 2024-01-25T10:48:42Z | |
| dc.date.issued | 2023-05-24 | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Seefried L, Bravenboer N, Imel EA. Editorial: Rare musculoskeletal disorders: disease mechanisms and therapies. Front Endocrinol (Lausanne). 2023;14:1215941. Published 2023 May 24. doi:10.3389/fendo.2023.1215941 | |
| dc.identifier.uri | https://hdl.handle.net/1805/38180 | |
| dc.language.iso | en_US | |
| dc.publisher | Frontiers Media | |
| dc.relation.isversionof | 10.3389/fendo.2023.1215941 | |
| dc.relation.journal | Frontiers in Endocrinology | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | ANO5 gene | |
| dc.subject | X-linked hypophosphataemia (XLH) | |
| dc.subject | Bone diseases | |
| dc.subject | Osteogenesis imperfecta | |
| dc.subject | Rare skeletal disorders | |
| dc.title | Editorial: Rare musculoskeletal disorders: disease mechanisms and therapies | |
| dc.type | Article |